Literature DB >> 29332028

Possible erythrocyte contributions to and exacerbation of the post-thrombolytic no-reflow phenomenon.

Shang-Jen Yu1, James P Buerck1, Edgar A O'Rear1, Thomas L Whitsett2.   

Abstract

BACKGROUND: Reperfusion injury often occurs with therapeutic intervention addressing the arterial occlusions causing acute myocardial infarction and stroke. The no-reflow phenomenon has been ascribed to leukocyte plugging and blood vessel constriction in the microcirculation.
OBJECTIVE: To assess possible red cell contributions to post-thrombolytic no-reflow phenomenon.
METHODS: Blood clots were formed by recalcifying 1 ml of citrated fresh human venous blood and then lysed by adding 1,000 units of streptokinase (SK) at several intervals within 1 hour. Red cell deformability was tested by both a microscopic photometric and a filtration technique, viscosity by a cone and plate viscometer, and erythrocyte aggregation by an optical aggregometer.
RESULTS: Two sampling methods were devised for the microscopic photometric test, both of which indicated increases of erythrocyte stiffness after being lysed from the clot by SK. In accompanying experiments, the viscosity, aggregation and filterability of the post-lytic erythrocytes were assessed. Results indicated increased viscosity in Ringer's, decreased aggregation index and filterability through a 5 μm pore size Nuclepore membrane.
CONCLUSION: Findings demonstrated that post-lytic changes in red cell deformability do occur which could contribute to the no-reflow phenomenon.

Entities:  

Keywords:  No-reflow phenomenon; erythrocyte deformability; reperfusion injury; stroke; thrombolysis

Mesh:

Substances:

Year:  2018        PMID: 29332028     DOI: 10.3233/BIR-17144

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  1 in total

1.  Thrombotic Microangiopathy Score as a New Predictor of Neurologic Outcomes in Patients after Out-of-Hospital Cardiac Arrest.

Authors:  Je Sung You; Hye Sun Lee; Soyoung Jeon; Jong Wook Lee; Hyun Soo Chung; Sung Phil Chung; Taeyoung Kong
Journal:  Yonsei Med J       Date:  2022-05       Impact factor: 3.052

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.